Total Payments
$121,832
2024 Payments
$12,580
Companies
76
Transactions
1,745
Medicare Patients
6,249
Medicare Billing
$844,643
Payment Breakdown by Category
Other$61,948 (50.8%)
Food & Beverage$29,454 (24.2%)
Consulting$24,162 (19.8%)
Travel$5,631 (4.6%)
Education$638.10 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $52,865 | 37 | 43.4% |
| Food and Beverage | $29,454 | 1,640 | 24.2% |
| Consulting Fee | $24,162 | 9 | 19.8% |
| Travel and Lodging | $5,631 | 20 | 4.6% |
| Honoraria | $5,388 | 6 | 4.4% |
| Compensation for serving as faculty or as a speaker for a medical education program | $2,695 | 3 | 2.2% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $1,000 | 1 | 0.8% |
| Education | $638.10 | 29 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $42,393 | 105 | $0 (2023) |
| GENZYME CORPORATION | $34,309 | 77 | $0 (2023) |
| Eisai Inc. | $10,506 | 49 | $0 (2024) |
| Lundbeck LLC | $6,316 | 55 | $0 (2024) |
| LivaNova USA, Inc. | $3,833 | 44 | $0 (2024) |
| UCB, Inc. | $3,150 | 174 | $0 (2024) |
| Biogen, Inc. | $2,065 | 119 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,518 | 119 | $0 (2023) |
| Medtronic USA, Inc. | $1,421 | 10 | $0 (2020) |
| Genentech USA, Inc. | $1,325 | 71 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,580 | 116 | Eisai Inc. ($10,172) |
| 2023 | $3,924 | 182 | UCB, Inc. ($614.04) |
| 2022 | $9,144 | 201 | Teva Pharmaceuticals USA, Inc. ($5,257) |
| 2021 | $14,773 | 236 | Teva Pharmaceuticals USA, Inc. ($9,038) |
| 2020 | $6,852 | 148 | Teva Pharmaceuticals USA, Inc. ($2,137) |
| 2019 | $27,691 | 305 | GENZYME CORPORATION ($12,822) |
| 2018 | $27,993 | 238 | GENZYME CORPORATION ($12,708) |
| 2017 | $18,874 | 319 | Teva Pharmaceuticals USA, Inc. ($6,315) |
All Payment Transactions
1,745 individual payment records from CMS Open Payments — Page 1 of 70
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $19.33 | General |
| Category: Neuroscience | ||||||
| 12/17/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $4.77 | General |
| Category: Neurology | ||||||
| 12/16/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $6.90 | General |
| Category: Neurology | ||||||
| 12/10/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $10.96 | General |
| Category: Neurology | ||||||
| 12/05/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Immunology | ||||||
| 11/20/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $53.35 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: EPILEPSY | ||||||
| 11/19/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/19/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $12.52 | General |
| Category: Neuroscience | ||||||
| 11/18/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Neurology | ||||||
| 11/08/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Neuroscience | ||||||
| 11/07/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $32.50 | General |
| Category: Neurology | ||||||
| 10/29/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Neurology | ||||||
| 10/28/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Immunology | ||||||
| 10/19/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $35.16 | General |
| Category: Neurology | ||||||
| 10/18/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.09 | General |
| Category: Neuroscience | ||||||
| 10/17/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: EPILEPSY | ||||||
| 10/16/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: EPILEPSY | ||||||
| 10/15/2024 | Eisai Inc. | Leqembi (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $980.00 | General |
| Category: Neurology | ||||||
| 10/15/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Neurology | ||||||
| 10/09/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $100.00 | General |
| Category: Rare Disease | ||||||
| 10/08/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | Cash or cash equivalent | $121.96 | General |
| Category: Neuroscience | ||||||
| 10/01/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.55 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 09/24/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $8.14 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,740 | 1,938 | $769,436 | $220,346 |
| 2022 | 12 | 1,490 | 1,704 | $720,452 | $210,739 |
| 2021 | 13 | 1,576 | 1,785 | $737,601 | $229,288 |
| 2020 | 16 | 1,443 | 1,662 | $661,374 | $184,271 |
Total Patients
6,249
Total Services
7,089
Medicare Billing
$844,643
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 479 | 645 | $205,110 | $55,552 | 27.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 338 | 338 | $165,282 | $40,516 | 24.5% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 123 | 134 | $85,437 | $35,962 | 42.1% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 236 | 245 | $129,457 | $35,067 | 27.1% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 40 | 42 | $30,402 | $13,685 | 45.0% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 107 | 107 | $42,693 | $10,956 | 25.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 40 | 41 | $17,466 | $5,601 | 32.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 47 | 47 | $26,884 | $5,545 | 20.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 91 | 95 | $20,425 | $5,348 | 26.2% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 68 | 70 | $11,410 | $3,103 | 27.2% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 111 | 111 | $12,765 | $2,998 | 23.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $6,710 | $1,852 | 27.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 17 | $6,596 | $1,646 | 25.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 18 | 21 | $4,347 | $1,271 | 29.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $4,452 | $1,245 | 28.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 419 | 591 | $187,938 | $53,081 | 28.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 354 | 354 | $173,106 | $42,262 | 24.4% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 227 | 231 | $125,895 | $35,854 | 28.5% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 109 | 114 | $80,518 | $34,431 | 42.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 91 | 94 | $53,768 | $14,079 | 26.2% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 26 | 26 | $20,358 | $9,368 | 46.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 123 | 137 | $29,455 | $8,355 | 28.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 21 | 22 | $9,372 | $2,795 | 29.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 19 | 29 | $8,613 | $2,372 | 27.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 12 | 12 | $7,320 | $1,965 | 26.8% |
About Dr. Stacey Epps, M.D
Dr. Stacey Epps, M.D is a Neurology healthcare provider based in Chester, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154391571.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stacey Epps, M.D has received a total of $121,832 in payments from pharmaceutical and medical device companies, with $12,580 received in 2024. These payments were reported across 1,745 transactions from 76 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($52,865).
As a Medicare-enrolled provider, Epps has provided services to 6,249 Medicare beneficiaries, totaling 7,089 services with total Medicare billing of $844,643. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Chester, VA
- Active Since 01/26/2006
- Last Updated 06/02/2010
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1154391571
Products in Payments
- AUBAGIO (Drug) $33,955
- COPAXONE (Drug) $18,774
- AJOVY (Biological) $16,161
- Leqembi (Drug) $10,212
- AJOVY (Drug) $6,746
- ONFI (Drug) $5,637
- VNS Therapy (Device) $3,215
- Briviact (Drug) $2,062
- ACTIVA (Device) $1,421
- OCREVUS (Biological) $761.88
- NURTEC ODT (Drug) $751.15
- APTIOM (Drug) $739.78
- TYSABRI (Biological) $736.06
- Aimovig (Biological) $672.93
- ZEPOSIA (Drug) $642.51
- AIMOVIG (Biological) $627.21
- Rebif (Biological) $536.08
- TECFIDERA (Drug) $493.43
- UBRELVY (Drug) $433.25
- QULIPTA (Drug) $422.43
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Chester
Dr. Pasquale Brancazio, Do, DO
Neurology — Payments: $23,040
Neurology $23,040
Dr. Mudassar Asghar, M.d, M.D
Neurology — Payments: $6,771
Neurology $6,771
Dr. Norman Leopold, Do, DO
Neurology — Payments: $4,678
Neurology $4,678
Dr. David Sirken, Do, DO
Neurology — Payments: $4,086
Neurology $4,086
Dr. Annmarie Gaskin, Md, MD
Neurology — Payments: $4,041
Neurology $4,041
Nicholas Beam
Neurology — Payments: $988.70
Neurology $988.70